These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23869443)

  • 21. Widespread coronary inflammation in unstable angina.
    Buffon A; Biasucci LM; Liuzzo G; D'Onofrio G; Crea F; Maseri A
    N Engl J Med; 2002 Jul; 347(1):5-12. PubMed ID: 12097534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
    Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
    Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease.
    Pawlus J; Hołub M; Kozuch M; Dabrowska M; Dobrzycki S
    Int J Lab Hematol; 2010 Jun; 32(3):320-8. PubMed ID: 20201999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic inflammatory status in patients with coronary artery ectasia.
    Li JJ; Nie SP; Qian XW; Zeng HS; Zhang CY
    Cytokine; 2009 Apr; 46(1):61-4. PubMed ID: 19232498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.
    Kubala L; Lu G; Baldus S; Berglund L; Eiserich JP
    Clin Chim Acta; 2008 Aug; 394(1-2):59-62. PubMed ID: 18440308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion.
    Baldus S; Heitzer T; Eiserich JP; Lau D; Mollnau H; Ortak M; Petri S; Goldmann B; Duchstein HJ; Berger J; Helmchen U; Freeman BA; Meinertz T; Münzel T
    Free Radic Biol Med; 2004 Sep; 37(6):902-11. PubMed ID: 15304260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation.
    El Kebir D; József L; Pan W; Filep JG
    Circ Res; 2008 Aug; 103(4):352-9. PubMed ID: 18617697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.
    Wainstein RV; Wainstein MV; Ribeiro JP; Dornelles LV; Tozzati P; Ashton-Prolla P; Ewald IP; Vietta G; Polanczyk CA
    Clin Biochem; 2010 Jan; 43(1-2):57-62. PubMed ID: 19651119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
    Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
    Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
    Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Watanabe K; Fukushima H; Tanaka T; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2005 May; 45(10):1622-30. PubMed ID: 15893178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low serum PON1 activity: an independent risk factor for coronary artery disease in North-West Indian type 2 diabetics.
    Gupta N; Binu KB; Singh S; Maturu NV; Sharma YP; Bhansali A; Gill KD
    Gene; 2012 Apr; 498(1):13-9. PubMed ID: 22333293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.
    Stefanescu A; Braun S; Ndrepepa G; Koppara T; Pavaci H; Mehilli J; Schömig A; Kastrati A
    Am Heart J; 2008 Feb; 155(2):356-60. PubMed ID: 18215608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential leucocyte RNA expression in the coronary arteries compared to systemic circulation discriminates between patients with and those without coronary artery disease.
    Ribalta J; Alipour A; Sánchez-Cabo F; Vallvé JC; Njo T; Álvarez R; Janssen H; Liem A; Dopazo A; Castro-Cabezas M
    Clin Investig Arterioscler; 2017; 29(2):60-66. PubMed ID: 28188023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of CD11a and CD45 on leukocytes and decreased serum TNF-alpha levels in patients with isolated coronary artery ectasia.
    Adiloglu AK; Ocal A; Tas T; Onal S; Kapan S; Aridogan B
    Clin Lab; 2011; 57(9-10):703-9. PubMed ID: 22029185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial nitric oxide synthase Glu298Asp (G894T) gene polymorphism in coronary artery disease patients with type 2 diabetes mellitus.
    Saini V; Bhatnagar MK; Bhattacharjee J
    Diabetes Metab Syndr; 2012; 6(2):106-9. PubMed ID: 23153979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease.
    Szodoray P; Timar O; Veres K; Der H; Szomjak E; Lakos G; Aleksza M; Nakken B; Szegedi G; Soltesz P
    Scand J Immunol; 2006 Sep; 64(3):336-44. PubMed ID: 16918703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between myeloperoxidase levels and risk of coronary artery disease.
    Zhang R; Brennan ML; Fu X; Aviles RJ; Pearce GL; Penn MS; Topol EJ; Sprecher DL; Hazen SL
    JAMA; 2001 Nov; 286(17):2136-42. PubMed ID: 11694155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.